<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211228053555N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-26</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>Effect of the neurofeedback and cognitive rehabilitation in the elderly</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of neurofeedback and cognitive rehabilitation on balance and cognitive function in the elderly</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60927</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using sealed envelopes participants were randomly assigned to one of the three groups of study. The envelopes received numbers in advance (coded as 1, 2, and 3), and were opened sequentially, only after the participant’s name was written on the appropriate envelope. Random allocation sequences remained concealed from those enrolling participants into the study to minimize the effects of bias, Blinding description: Data for all subjects were obtained, by an investigator who was blinded to the treatment allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The elderly.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: Neurofeedback                                       Neurofeedback therapy involve 16 sessions, with two sessions per week. Neurofeedback training will be conducted using neurofeedback devices with Procomp hardware (Ver.0.5,) and Biography software produced by TAT Technologies Company (Thought Technology Ltd, Canada The method of electrode placement in this protocol is that the active electrode (0.01 reference electrode) will be placed on (the cerebellum) and the grand electrode will be placed on the right ear. Then, in the intervention phase, animation will present to them. As the brain waves of the elderly move away from the intended target (ie, increasing the theta wave and decreasing the beta waves), the animation will stop. To replay the animation, the elderly have to change their brain waves in the direction of the intended target. Intervention 2: Intervention group2: Cognitive rehabilitation                                                 In this study, Captain Log cognitive rehabilitation treatment is performed in 16 sessions, 2 times a week for 60 minutes each time.The Captain Log program is one of the software programs designed by Train Brain in the United States to rehabilitate and enhance cognitive functions. This set has 2000 different programs and assignments and includes basic cognitive skills and superior skills. Also, this software set has three levels: simple, medium and difficult, which are determined according to the subject's condition. Intervention 3: Intervention group 3:Neurofeedback + Cognitive Neurofeedback therapy  In total, this group has 4 treatment sessions per week, including two neurofeedback sessions and two cognitive therapy sessions.Neurofeedback therapy involve 16 sessions, with two sessions per week. Captain Log cognitive rehabilitation treatment is performed in 16 sessions, 2 times a week for 60 minutes each time. Intervention 4: Control group: This group does not receive treatment. Only every week their conditions are checked by phone.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic information and information on the main outcome

When:
Start of access period from 1401

To whom:
Researchers working in academic institutions and clinics

Conditions:
Use for further research and review articles

Where to obtain:
Seyed Abolfazl Mousavi

How to obtain:
Two weeks to review the request and check the purpose of receiving the data

Comments:
Because the condition we are studying is not a disease, we leave the ICD-10 code and ICD-10 code description fields empty according to your guidline.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Abolfazl Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 7, Baran Building , Falsafy Alley, Between Mirdamad and Zafar Ave, Shariati St,Tehran Town.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985713871</zip>
        <telephone>+98 919 300 3160</telephone>
        <email>seyed.abalfazl@gmail.com</email>
        <affiliation>Movafaghiyat Clinic</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Abolfazl Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 7, Baran Building , FalsaFy Alley, Between Mirdamad and Zafar Ave, Shariati St,Tehran Town.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985713871</zip>
        <telephone>+98 919 300 3160</telephone>
        <email>seyed.abalfazl@gmail.com</email>
        <affiliation>Movafaghiyat clinic</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Those elderly who do not have cranial implants
Those elderly who are able to walk independently without assistive devices
Those elderly who have conscious consent to participate in research
Those elderly who have no history of attending psychotherapy and neurofeedback sessions</inclusion_criteria>
      <agemin>65 years</agemin>
      <agemax>74 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>old people with a definite diagnosis of neurological disorders, orthopedic disorders and cardiovascular and respiratory diseases
old people with a visual or vestibular impairment, or those who taking medications which cause balance problems
the elderly who had a score below 7 on the Brief cognitive test
Personal reluctance to continue treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: Neurofeedback                                       Neurofeedback therapy involve 16 sessions, with two sessions per week. Neurofeedback training will be conducted using neurofeedback devices with Procomp hardware (Ver.0.5,) and Biography software produced by TAT Technologies Company (Thought Technology Ltd, Canada The method of electrode placement in this protocol is that the active electrode (0.01 reference electrode) will be placed on (the cerebellum) and the grand electrode will be placed on the right ear. Then, in the intervention phase, animation will present to them. As the brain waves of the elderly move away from the intended target (ie, increasing the theta wave and decreasing the beta waves), the animation will stop. To replay the animation, the elderly have to change their brain waves in the direction of the intended target.</i_keyword>
      <i_keyword>Intervention group2: Cognitive rehabilitation                                                 In this study, Captain Log cognitive rehabilitation treatment is performed in 16 sessions, 2 times a week for 60 minutes each time.The Captain Log program is one of the software programs designed by Train Brain in the United States to rehabilitate and enhance cognitive functions. This set has 2000 different programs and assignments and includes basic cognitive skills and superior skills. Also, this software set has three levels: simple, medium and difficult, which are determined according to the subject's condition.</i_keyword>
      <i_keyword>Intervention group 3:Neurofeedback + Cognitive Neurofeedback therapy  In total, this group has 4 treatment sessions per week, including two neurofeedback sessions and two cognitive therapy sessions.Neurofeedback therapy involve 16 sessions, with two sessions per week. Captain Log cognitive rehabilitation treatment is performed in 16 sessions, 2 times a week for 60 minutes each time..</i_keyword>
      <i_keyword>Control group: This group does not receive treatment. Only every week their conditions are checked by phone.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Cognitive function. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Mini-Mental State Examination, Montreal Cognitive Assessment.</prim_outcome>
      <prim_outcome>Balance. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Timed Up and Go test, the Berg Balance Scale (BBS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Risk of falling. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Tinetti balance score.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-12-27</approval_date>
        <contact_name>Ethics committee of University of Social Welfare and Rehabilitation Sciences</contact_name>
        <contact_address>kodakyar Ave, Daneshjoo Blvd, Evin,Tehran, University of Social Welfare and Rehabilitation Science Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
